Cargando…
Genetically modified human placenta-derived mesenchymal stem cells with FGF-2 and PDGF-BB enhance neovascularization in a model of hindlimb ischemia
Ischemic diseases represent a challenging worldwide health burden. The current study investigated the therapeutic potential of genetically modified human placenta-derived mesenchymal stem cells (hPDMSCs) with basic fibroblast growth factor (FGF2) and platelet-derived growth factor-BB (PDGF-BB) genes...
Autores principales: | YIN, TAO, HE, SISI, SU, CHAO, CHEN, XIANCHENG, ZHANG, DONGMEI, WAN, YANG, YE, TINGHONG, SHEN, GUOBO, WANG, YONGSHENG, SHI, HUASHAN, YANG, LI, WEI, YUQUAN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581748/ https://www.ncbi.nlm.nih.gov/pubmed/26239842 http://dx.doi.org/10.3892/mmr.2015.4089 |
Ejemplares similares
-
Inhibition of PDGF-BB reduces alkali-induced corneal neovascularization in mice
por: Chen, Lei, et al.
Publicado: (2021) -
Serial measurements of serum PDGF-AA, PDGF-BB, FGF2, and VEGF in multiresistant ovarian cancer patients treated with bevacizumab
por: Madsen, Christine Vestergaard, et al.
Publicado: (2012) -
Antitumor Activities of Human Placenta-Derived Mesenchymal Stem Cells Expressing Endostatin on Ovarian Cancer
por: Zheng, Lan, et al.
Publicado: (2012) -
PDGF-AA and PDGF-BB biosynthesis: proprotein processing in the Golgi complex and lysosomal degradation of PDGF-BB retained intracellularly
Publicado: (1992) -
Low plasma PDGF-BB levels are associated with estradiol in postmenopausal osteoporosis: PDGF-BB mediated by estradiol in women
por: Tang, Lanhua, et al.
Publicado: (2017)